Skip to Content
Merck
HomeProductsChemistry & BiochemicalsChemical SynthesisCoupling Reagents & Nucleosides

Coupling Reagents & Nucleosides

Slide 1 of 2
1 of 2
Oligo synthesis cycle A

Oligo Synthesis Cycle

Oligo Synthesis Cycle B

Oligo Synthesis Cycle

We offer a collection of useful building blocks, coupling reagents, and nucleosides for applications in oligo synthesis and beyond. Nucleosides and modified nucleosides are the basic structural units that make up nucleic acids (DNA and RNA), which are responsible for encoding, transmitting and expressing genetic information in all living things. Oligonucleotide synthesis outside of biological systems is the chemical synthesis of nucleic acids of a predetermined sequence that may contain nucleosides beyond those that are naturally occurring. Typical oligonucleotide synthesis using nucleoside phosphoramidites occurs in a four-step process: deblocking, coupling, capping, and oxidation. Coupling reagents play an important role in these steps, efficient coupling activators assuring the reactions are fast and nearly quantitative. 

The ability to incorporate non-natural nucleosides into nucleic acids has led to many research uses such as:

  • sequence detection 
  • hydrolysis resistance
  • sequencing
  • enzyme inhibition

Nucleoside chemistry has produced non-natural analogs that have been useful in medicine with chemotherapeutic and antiviral applications, such as reverse transcriptase inhibition. Our selection of unnatural bases, nucleoside derivatives and intermediates will provide you with a useful starting point for your oligo or nucleoside analog synthesis needs.

Related Product Categories
Organic Building Blocks
Find the basic components needed to drive your research forward in our portfolio of organic building blocks. Alkenesm alkanes, alkynes, arenes, allenes & more!
Related Applications
Peptide Synthesis
Peptide synthesis involves the formation of a peptide bond between two amino acids to create a peptide composed of a chain of multiple amino acids.
Targeted Protein Degradation
Targeted protein degradation (TPD) is an emerging drug discovery strategy that uses small-molecules, such as proteolysis-targeting chimeras (PROTACs), to eradicate targeted proteins linked to disease from cells.
ADC & Bioconjugation
Bioconjugation involves ligating molecules together in which at least one of the reactants is a biomolecule, often an antibody, protein, or oligonucleotide, for detection, assay, or targeting and tracking of the biomolecule.
Related Services
Oligos, qPCR Probes & Peptides
Choose custom products from our comprehensive portfolio of DNA and RNA oligos, qPCR probes and peptides as we offer numerous options for manufacturing platforms, purity levels, modifications to meet a variety of research applications.
Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?